Quote this publication Share Print

LIPANTHYL - FENOFIBRATE FOURNIER - SECALIP

-
Opinions on drugs - Posted on Apr 16 2014

Reason for request

Renewal of inclusion

-


Clinical Benefit

Substantial

The actual benefit of LIPANTHYL, SECALIP and FENOFIBRATE FOURNIER is substantial in the extension of indication " together with a suitable diet and other non-pharmacological treatments (e.g. exercise, weight reduction) in the case of mixed hyperlipidaemia in patients at high cardiovascular risk, in addition to a statin when triglycerides and HDL cholesterol are not adequately controlled."